Results 41 to 50 of about 16,074 (213)

PFA-100 test in the detection of platelet dysfunction and monitoring DDAVP in a patient with liver cirrhosis undergoing inguinal hernia repair [PDF]

open access: yesSrpski Arhiv za Celokupno Lekarstvo, 2012
Introduction. Hemostatic abnormalities in liver cirrhosis are complex and multifactorial and may predispose to prolonged hemorrhage following invasive procedures.
Vučelić Dragica   +2 more
doaj   +1 more source

The novel desmopressin analogue [V4Q5]dDAVP inhibits angiogenesis, tumour growth and metastases in vasopressin type 2 receptor-expressing breast cancer models [PDF]

open access: yes, 2015
Desmopressin (dDAVP) is a safe haemostatic agent with previously reported antitumour activity. It acts as a selective agonist for the V2 vasopressin membrane receptor (V2r) present on tumour cells and microvasculature.
Alonso, Daniel Fernando   +9 more
core   +1 more source

Acquired von Willebrand syndrome in monoclonal gammopathy – A scoping review on hemostatic management

open access: yesResearch and Practice in Thrombosis and Haemostasis, 2021
Background Acquired von Willebrand syndrome (AVWS) has been associated with monoclonal gammopathy of undetermined significance (MGUS), with limited data on its management. Methods We conducted a systematic literature search in Medline (Ovid), Embase, and
Mouhamed Yazan Abou‐Ismail   +3 more
doaj   +1 more source

Synthesis and binding characteristics of two sulfhydryl-reactive probes for vasopressin receptors [PDF]

open access: yes, 1993
The present study describes the synthesis and receptor binding affinities of the sulfhydryl-reactive vasopressin analogs deamino[Dab(N8-N-maleoyl-β-alanin e)4]AVP (1a) and deamino[Lys(N8-N-maleoyl-β-alanine)8VP (2a).
Fahrenholz, Falk   +2 more
core   +1 more source

Vasopressin and oxytocin receptors in GtoPdb v.2023.1 [PDF]

open access: yes, 2023
Vasopressin (AVP) and oxytocin (OT) receptors (nomenclature as recommended by NC-IUPHAR [94]) are activated by the endogenous cyclic nonapeptides vasopressin and oxytocin.
Bichet, Daniel   +15 more
core   +2 more sources

Pharmacological interventions for the prevention of bleeding in people undergoing elective hip or knee surgery: a systematic review and network meta‐analysis [PDF]

open access: yes, 2019
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To determine the relative efficacy of pharmacological interventions for preventing blood loss in elective primary or revision hip or knee replacement, and to identify
Champaneria, R   +4 more
core   +2 more sources

Low COAT platelets are frequent in patients with bleeding disorders of unknown cause (BDUC) and can be enhanced by DDAVP

open access: yes, 2022
Journal of Thrombosis and Haemostasis, Volume 20, Issue 5, Page 1271-1274, May 2022.
Amandine Segot   +8 more
wiley   +1 more source

Effect of Desmopressin on Platelet Aggregation and Blood Loss in Patients Undergoing Valvular Heart Surgery

open access: yesChinese Medical Journal, 2015
Background: Blood loss after cardiac surgery can be caused by impaired platelet (PLT) function after cardiopulmonary bypass. Desmopressin or 1-deamino-8-D-arginine vasopressin (DDAVP) is a synthetic analog of vasopressin.
Lei Jin, Hong-Wen Ji
doaj   +1 more source

Acute fatty liver during pregnancy and gestational diabetes insipidus: a case report

open access: yesClinical and Experimental Obstetrics & Gynecology, 2020
Acute fatty liver during pregnancy (AFLP) is an emergency and potentially fatal condition occurring during the peripartum period. It is characterized by fatty microvascular infiltration of hepatocytes and has an incidence rate of approximately one in 7 ...
H.J. Wang, T.H. Chou, Y.C. Lee, H.K. Au
doaj   +1 more source

Home - About - Disclaimer - Privacy